Rolapitant for the treatment of chemotherapy-induced nausea and vomiting
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rolapitant for the treatment of chemotherapy-induced nausea and vomiting
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 15, Issue 10, Pages 1127-1133
Publisher
Informa UK Limited
Online
2015-09-25
DOI
10.1586/14737140.2015.1088787
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemotherapy-Induced Nausea and Vomiting: Time for More Emphasis on Nausea?
- (2015) T. L. Ng et al. ONCOLOGIST
- Aprepitant and Fosaprepitant: A 10-Year Review of Efficacy and Safety
- (2015) M. Aapro et al. ONCOLOGIST
- Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
- (2014) P. J. Hesketh et al. ANNALS OF ONCOLOGY
- A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy
- (2014) R. J. Gralla et al. ANNALS OF ONCOLOGY
- A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy
- (2014) M. Aapro et al. ANNALS OF ONCOLOGY
- Palonosetron for the treatment of chemotherapy-induced nausea and vomiting
- (2014) Rudolph M Navari EXPERT OPINION ON PHARMACOTHERAPY
- Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review
- (2014) Christopher M. Hocking et al. SUPPORTIVE CARE IN CANCER
- Management of Chemotherapy-Induced Nausea and Vomiting
- (2013) Rudolph M. Navari DRUGS
- Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting
- (2013) Rudolph M. Navari EUROPEAN JOURNAL OF PHARMACOLOGY
- Netupitant PET imaging and ADME studies in humans
- (2013) Tulla Spinelli et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
- (2012) Antonio Rossi et al. JOURNAL OF CLINICAL ONCOLOGY
- In vitro and in vivo pharmacological characterization of the novel NK1 receptor selective antagonist Netupitant
- (2012) Anna Rizzi et al. PEPTIDES
- Rolapitant (SCH 619734): A potent, selective and orally active neurokinin NK1 receptor antagonist with centrally-mediated antiemetic effects in ferrets
- (2012) Ruth A. Duffy et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE
- (2011) Steven Grunberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2011) Ethan Basch et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
- (2009) Lijun Tan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started